|
1
|
Luetke A, Meyers PA, Lewis A and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ward E, DeSantis C, Robbins A, Kohler B
and Jemal A: Childhood and adolescent cancer statistics, 2014. CA
Cancer J Clin. 64:83–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kleinerman E: Maximum benefit of
chemotherapy for osteosarcoma achieved-what are the next steps?
Lancet Oncol. 17:1340–1342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cates JM: Utility of examination of biopsy
tracts in osteosarcoma resection specimens. Am J Clin Pathol.
146:324–327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilkins RM, Cullen JW, Odom L, Jamroz BA,
Cullen PM, Fink K, Peck SD, Stevens SL, Kelly CM and Camozzi AB:
Superior survival in treatment of primary non-metastatic pediatric
osteosarcoma of the extremity. Ann Surg Oncol. 10:498–507. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lionetti M, Agnelli L, Mosca L, Fabris S,
Andronache A, Todoerti K, Ronchetti D, Deliliers GL and Neri A:
Integrative high-resolution microarray analysis of human myeloma
cell lines reveals deregulated miRNA expression associated with
allelic imbalances and gene expression profiles. Genes Chromosomes
Cancer. 48:521–531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Visone R and Croce CM: MiRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai J, Zhao J, Zhang N, Xu X, Li R, Yi Y,
Fang L, Zhang L, Li M, Wu J and Zhang H: MicroRNA-542-3p suppresses
tumor cell invasion via targeting AKT pathway in human astrocytoma.
J Biol Chem. 290:24678–24688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Althoff K, Lindner S, Odersky A, Mestdagh
P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, et al: miR-542-3p exerts tumor suppressive functions in
neuroblastoma by downregulating Survivin. Int J Cancer.
136:1308–1320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu W, Dang S, Feng Q, Liang J, Wang Y and
Fan N: MicroRNA-542-3p inhibits the growth of hepatocellular
carcinoma cells by targeting FZD7/Wnt signaling pathway. Biochem
Biophys Res Commun. 482:100–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Venkatadri R, Muni T, Iyer AK, Yakisich JS
and Azad N: Role of apoptosis-related miRNAs in resveratrol-induced
breast cancer cell death. Cell Death Dis. 7:e21042016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Long HC, Gao X, Lei CJ, Zhu B, Li L, Zeng
C, Huang JB and Feng JR: miR-542-3p inhibits the growth and
invasion of colorectal cancer cells through targeted regulation of
cortactin. Int J Mol Med. 37:1112–1118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rang Z, Yang G, Wang YW and Cui F:
miR-542-3p suppresses invasion and metastasis by targeting the
proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Biochem Biophys Res Commun. 474:315–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon S, Choi YC, Lee S, Jeong Y, Yoon J
and Baek K: Induction of growth arrest by miR-542-3p that targets
survivin. FEBS Lett. 584:4048–4052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He T, Qi F, Jia L, Wang S, Song N, Guo L,
Fu Y and Luo Y: MicroRNA-542-3p inhibits tumour angiogenesis by
targeting angiopoietin-2. J Pathol. 232:499–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vlachos IS, Paraskevopoulou MD, Karagkouni
D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL,
Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0:
Indexing more than half a million experimentally supported miRNA:
mRNA interactions. Nucleic Acids Res. 43:(Database Issue).
D153–D159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brown KA, Pietenpol JA and Moses HL: A
tale of two proteins: Differential roles and regulation of Smad2
and Smad3 in TGF-beta signaling. J Cell Biochem. 101:9–33. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bao Y, Chen Z, Guo Y, Feng Y, Li Z, Han W,
Wang J, Zhao W, Jiao Y, Li K, et al: Tumor suppressor microRNA-27a
in colorectal carcinogenesis and progression by targeting SGPP1 and
smad2. PLoS One. 9:e1059912014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lagmay JP, Krailo MD, Dang H, Kim A,
Hawkins DS, Beaty O III, Widemann BC, Zwerdling T, Bomgaars L,
Langevin AM, et al: Outcome of patients with recurrent osteosarcoma
enrolled in seven phase II trials through children's cancer group,
pediatric oncology group, and children's oncology group: Learning
from the past to move forward. J Clin Oncol. 34:3031–3038. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baumann S and Hennet T: Collagen
accumulation in osteosarcoma cells lacking GLT25D1 collagen
galactosyltransferase. J Biol Chem. 291:18514–18524. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Angelini A, Mavrogenis AF, Trovarelli G,
Ferrari S, Picci P and Ruggieri P: Telangiectatic osteosarcoma: A
review of 87 cases. J Cancer Res Clin Oncol. 142:2197–2207. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buondonno I, Gazzano E, Jean SR, Audrito
V, Kopecka J, Fanelli M, Salaroglio IC, Costamagna C, Roato I,
Mungo E, et al: Mitochondria-targeted doxorubicin: A new
therapeutic strategy against doxorubicin-resistant osteosarcoma.
Mol Cancer Ther. 15:2640–2652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Wang S, Han F, Li J, Yu L, Zhou
P, Chen Z, Xue S, Dai C and Li Q: MicroRNA-542-3p suppresses
cellular proliferation of bladder cancer cells through
post-transcriptionally regulating survivin. Gene. 579:146–152.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kureel J, Dixit M, Tyagi AM, Mansoori MN,
Srivastava K, Raghuvanshi A, Maurya R, Trivedi R, Goel A and Singh
D: miR-542-3p suppresses osteoblast cell proliferation and
differentiation, targets BMP-7 signaling and inhibits bone
formation. Cell Death Dis. 5:e10502014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mishra L, Derynck R and Mishra B:
Transforming growth factor-beta signaling in stem cells and cancer.
Science. 310:68–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: The molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
